» Articles » PMID: 36752796

CTCF Mediates CD8+ Effector Differentiation Through Dynamic Redistribution and Genomic Reorganization

Overview
Journal J Exp Med
Date 2023 Feb 8
PMID 36752796
Authors
Affiliations
Soon will be listed here.
Abstract

Differentiation of effector CD8+ T cells is instructed by stably and dynamically expressed transcription regulators. Here we show that naive-to-effector differentiation was accompanied by dynamic CTCF redistribution and extensive chromatin architectural changes. Upon CD8+ T cell activation, CTCF acquired de novo binding sites and anchored novel chromatin interactions, and these changes were associated with increased chromatin accessibility and elevated expression of cytotoxic program genes including Tbx21, Ifng, and Klrg1. CTCF was also evicted from its ex-binding sites in naive state, with concomitantly reduced chromatin interactions in effector cells, as observed at memory precursor-associated genes including Il7r, Sell, and Tcf7. Genetic ablation of CTCF indeed diminished cytotoxic gene expression, but paradoxically elevated expression of memory precursor genes. Comparative Hi-C analysis revealed that key memory precursor genes were harbored within insulated neighborhoods demarcated by constitutive CTCF binding, and their induction was likely due to disrupted CTCF-dependent insulation. CTCF thus promotes cytotoxic effector differentiation by integrating local chromatin accessibility control and higher-order genomic reorganization.

Citing Articles

A PI3Kδ-Foxo1-FasL signaling amplification loop rewires CD4 T helper cell signaling, differentiation and epigenetic remodeling.

Golec D, Gazzinelli-Guimaraes P, Chauss D, Nagashima H, Yu K, Hill T bioRxiv. 2025; .

PMID: 39803425 PMC: 11722529. DOI: 10.1101/2024.10.28.620691.


Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansion.

Fiorenza S, Zheng Y, Purushe J, Bock T, Sarthy J, Janssens D Nat Commun. 2024; 15(1):8309.

PMID: 39333103 PMC: 11436946. DOI: 10.1038/s41467-024-52503-2.


Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8 T cell effector differentiation and anti-tumor immunity.

Sun L, Jiao A, Liu H, Ding R, Yuan N, Yang B Signal Transduct Target Ther. 2024; 9(1):152.

PMID: 38918390 PMC: 11199508. DOI: 10.1038/s41392-024-01873-6.


Deciphering the TET3 interactome in primary thymic developing T cells.

Theofilatos D, Ho T, Waitt G, Aijo T, Schiapparelli L, Soderblom E iScience. 2024; 27(5):109782.

PMID: 38711449 PMC: 11070343. DOI: 10.1016/j.isci.2024.109782.


The transcriptional cofactor Tle3 reciprocally controls effector and central memory CD8 T cell fates.

Zhao X, Hu W, Park S, Zhu S, Hu S, Zang C Nat Immunol. 2024; 25(2):294-306.

PMID: 38238608 PMC: 10916363. DOI: 10.1038/s41590-023-01720-w.


References
1.
Skene P, Henikoff S . An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. Elife. 2017; 6. PMC: 5310842. DOI: 10.7554/eLife.21856. View

2.
Gullicksrud J, Li F, Xing S, Zeng Z, Peng W, Badovinac V . Differential Requirements for Tcf1 Long Isoforms in CD8 and CD4 T Cell Responses to Acute Viral Infection. J Immunol. 2017; 199(3):911-919. PMC: 5531591. DOI: 10.4049/jimmunol.1700595. View

3.
Chung H, McDonald B, Kaech S . The architectural design of CD8+ T cell responses in acute and chronic infection: Parallel structures with divergent fates. J Exp Med. 2021; 218(4). PMC: 7992501. DOI: 10.1084/jem.20201730. View

4.
Shan Q, Zhu S, Chen X, Liu J, Yuan S, Li X . Tcf1-CTCF cooperativity shapes genomic architecture to promote CD8 T cell homeostasis. Nat Immunol. 2022; 23(8):1222-1235. PMC: 9579964. DOI: 10.1038/s41590-022-01263-6. View

5.
Arsenio J, Metz P, Chang J . Asymmetric Cell Division in T Lymphocyte Fate Diversification. Trends Immunol. 2015; 36(11):670-683. PMC: 4640954. DOI: 10.1016/j.it.2015.09.004. View